Get started
Author

María Calatayud

Observed names: Calatayud, María, M. Calatayud, Maria Calatayud
Observed institutions: Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre, Institut d'Investigació Biomédica de Bellvitge, Spanish National Cancer Research Centre, Hospital Universitario 12 De Octubre, Sociedad Española de Endocrinología y Nutrición, Centre for Biomedical Network Research on Rare Diseases, Hospital Universitario Central de Asturias, Centro de Biología Molecular Severo Ochoa, Micro Vascular Theraputics (United States), University Hospital Carl Gustav Carus, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Technische Universität Dresden
ORCID: 0000-0002-6737-7289
Observed ORCID: 0000-0002-6737-7289
OpenAlex ID: A5084676295
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
2015 · Alberto Cascón, Iñaki Comino-Méndez, et al. · JNCI Journal of the National Cancer Institute · 205
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
2023 · Bruna Calsina, Elena Piñeiro-Yáñez, et al. · Nature Communications · 121
PDF
PheoSeq
2017 · Maria Currás-Freixes, Elena Piñeiro-Yañez, et al. · Journal of Molecular Diagnostics · 80
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma
2019 · Bruna Calsina, Luis Jaime Castro-Vega, et al. · Theranostics · 75
PDF
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients
2018 · Bruna Calsina, Maria Currás-Freixes, et al. · Genetics in Medicine · 73
Endoscopic Transnasal Trans-Sphenoidal Approach for Pituitary Adenomas: A Comparison to the Microscopic Approach Cohort by Propensity Score Analysis
2019 · Ana M Castaño-Leon, Igor Paredes, et al. · Neurosurgery · 42
Prevalencia de concentraciones deficientes e insuficientes de vitamina D en una población joven y sana
2009 · María Calatayud, Esteban Jódar, et al. · Endocrinología y Nutrición · 42
Personalized Medicine in Acromegaly: The ACROFAST Study
2024 · Montserrat Marques-Pamies, Joan Gil, et al. · The Journal of Clinical Endocrinology & Metabolism · 34
PDF
Trabecular bone score and bone mineral density in patients with long‐term controlled acromegaly
2021 · María Calatayud, Laura Pérez‐Olivares Martín, et al. · Clinical Endocrinology · 34
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes
2023 · Marta Araujo-Castro, Miguel Paja Fano, et al. · Endocrine Connections · 32
PDF
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
2024 · Marta Araujo-Castro, Betina Biagetti, et al. · The Journal of Clinical Endocrinology & Metabolism · 31
PDF
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
2021 · María Monteagudo, Paula Martínez, et al. · Cancers · 24
PDF
MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes
2019 · Cristina Lamas, Elena Navarro, et al. · Endocrine Connections · 23
PDF
Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
2020 · Alexandre Buffet, Bruna Calsina, et al. · Journal of Medical Genetics · 22
PDF
Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas
2023 · Marta Araujo-Castro, Iñigo García Sanz, et al. · Frontiers in Endocrinology · 20
PDF
Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study
2024 · Alessandro Parente, Kevin Verhoeff, et al. · European Urology Focus · 18
PDF
Differences in clinical, hormonal, and radiological presentation and in surgical outcomes in patients presenting with and without pituitary apoplexy. A multicenter study of 245 cases
2023 · Marta Araujo-Castro, Igor Paredes, et al. · Pituitary · 18
PDF
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
2024 · Betina Biagetti, Marta Araujo-Castro, et al. · European Journal of Endocrinology · 17
PDF
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
2023 · Sara Mellid, Eduardo Gil, et al. · Frontiers in Endocrinology · 16
PDF
Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas
2022 · Marta Araujo-Castro, César Mínguez Ojeda, et al. · Endocrine Related Cancer · 16
Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas
2023 · Marta Araujo-Castro, Iñigo García Sanz, et al. · Journal of Hypertension · 15
Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors
2025 · Marta Araujo-Castro, Edelmiro Menéndez Torre, et al. · The Journal of Clinical Endocrinology & Metabolism · 14
PDF
Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry
2024 · Marta Araujo-Castro, Miguel Paja Fano, et al. · Journal of Hypertension · 14
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
2024 · Eider Pascual-Corrales, Betina Biagetti, et al. · Pituitary · 13
Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY
2022 · M. Araujo-Castro, I. García Sanz, et al. · Journal of Endocrinological Investigation · 13
Works count: 90
Citation count: 1,237
H-index: 17
I10-index: 31
Year
Topic
Type